国产一区二区三区视频精品-国产一区二区三区视频在线观看-国产一区二区三区四区五区-国产一区二区三区四区五区精品-国产一区二区三区无码免费-国产一区二区三区在线

美國Nephros   
nephros公司，總部在新澤西州，是一家醫療器械公司，開發和銷售治療應用，感染控制，水凈化過濾產品。Nephros血液透析濾過（HDF）系統的設計，而解決的關鍵財務和臨床保健提供者的需求，改善終末期腎臟疾病（ESRD）患者的生活質量。終末期腎功能不可逆轉的喪失為特征的一種疾病狀態。Nephros的HDF系統更有效地消除各種有害物質，并具有更大的容量，比現有的終末期的治療方法，特別是就統稱為物質，“中間分子。” 這些分子已發現有助于透析相關性淀粉樣變，腕隧道癥候群，退化性骨骼疾病，并最終在終末期腎病患者的死亡率等條件。Nephros雙級超濾（DSU）Nephros水過濾產品線，其中包括密歇根州立大學和語常會辦事處超濾的基礎上。專利的雙級冷殺菌超濾過濾掉細菌，由于其特殊的過濾水平，篩選出很多病毒，寄生蟲和毒素的能力。Nephros DSU的密歇根州立大學，和語常會辦事處是FDA在血液透析過程中使用的生物污染物從水和碳酸氫鹽濃縮過濾清除。nephros“DSU的超濾正在評估在美國幾個主要的醫療中心感染控制。nephros還開發飲用水凈化UF-40超濾在戰場上的士兵。

Nephros, Inc. was founded in 1997 by Columbia University health for the End Stage Renal Disease (ESRD) patient, while addressing
the critical needs of the care provider. The Company has developed the most effective ESRD therapy available worldwide, offering unique
and proprietary technologies that dramatically improve clinical efficacy.
Nephros technologies also remove a range of harmful substances not currently removed by existing dialysis methods; addressed specifically
are substances known collectively as middle molecules, due to their molecular weight, that contribute to such conditions as carpal tunnel
syndrome, dialysis related amyloidosis, and degenerative bone disease in the ESRD patient.
Founded in 1997 to address current voids in ESRD treatment:

Stale Methodologies
Cost and Reimbursement Issues
Quality of Care Issues
Nephros technology focus:
Unique and cost-effective proprietary technologies
Marked improvements in treatment efficacy per unit time
Platforms: easy to use and maintain
Technology that integrates well with existing mfg and clinical
infrastructures